Description
Tirzepatide – 60mg Research-Grade Dual GLP-1/GIP Receptor Agonist Peptide
Tirzepatide is a synthetic peptide analog engineered to selectively activate both the
GLP-1 and GIP receptors, providing a dual-incretin mechanism of action. In controlled
laboratory environments, it is used to study multi-receptor GPCR signaling, intracellular
messenger formation, metabolic pathway cross-talk, and structure–activity relationships
associated with incretin hormone analogs.
In vitro, Tirzepatide enables precise evaluation of receptor-binding kinetics,
cyclic AMP (cAMP) signaling, biased GPCR activation, and peptide–fatty acid conjugation
effects on receptor engagement and stability. The modified C20 fatty-acid side chain
extends interaction duration, supporting studies requiring prolonged receptor activation
and detailed modeling of dual agonist behavior.
Supplied as a high-purity lyophilized peptide, Tirzepatide is suitable for biochemical
assays, GPCR interaction profiling, comparative incretin pathway research, and controlled
mechanistic experiments involving peptide-based metabolic signaling.
Important Information About This Research Product:
- Your vials are not empty — the lyophilized material collects at the bottom.
- All products arrive as lyophilized powder.
- Store in a cool, dry environment — short-term at 4°C, long-term at -20°C.
- This material is strictly for laboratory research use only —
no instructions for reconstitution, dosing, or administration can be provided.
